Georgia Keresty
CIK: 0001773532
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026SLDB
Solid Biosciences Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
77.5K shares- - Jun 9, 2026NTLA
Intellia Therapeutics, Inc.
Award(A)Direct9.2K shares- - Jun 12, 2025SLDB
Solid Biosciences Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
77.5K shares- - Jun 11, 2025NTLA
Intellia Therapeutics, Inc.
Award(A)Direct8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  SLDB Solid Biosciences Inc. | Award(A) Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Jun 9, 2026 |  NTLA Intellia Therapeutics, Inc. | Award(A) | 9,200 | - | $0 | Direct |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | Award(A) Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | Award(A) | 8,000 | - | - | Direct |
1-4 of 4 transactions
About Keresty Georgia
Keresty Georgia (SEC CIK 0001773532) files insider reports with the SEC as Director of Solid Biosciences Inc. (SLDB) and Director of Intellia Therapeutics, Inc. (NTLA).
Signal8 holds 4 ownership filings by Keresty Georgia, all Form 4s, filed between Jun 18, 2025 and Jun 11, 2026. Those filings report 4 transactions, from Jun 11, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Keresty Georgia's filings is in CAMBRIDGE, MA.
Recent filings by Keresty Georgia
Other insiders filing for Solid Biosciences Inc. (SLDB)
- Ganot Ilan, Director
- Brooks Gabriel, Chief Medical Officer
- SMITH IAN F, Director
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- Nagendran Sukumar, Director
- PERCEPTIVE ADVISORS LLC, Director